Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Table 1

Baseline characteristics of women by study group.

	Group
Measurements	Placebo (n=19)	Inulin (n=19)	p
Age (years)	51.89 (10.36)	51.58 (8.45)	0.919
Weight (kg)	61.97 (10.90)	69.16 (13.77)	0.083
Fasting glucose
Normal	11 (28.9)	4 (10.5)	0.045
High	8 (21.1)	15 (39.5)
Creatinine clearance
Low	8 (21.1)	7 (18.4)	0.999
Normal	11 (28.9)	12 (31.6)
Menopause
Premenopause	9 (23.7)	7 (18.4)	0.743
Postmenopause	10 (26.3)	12 (31.6)
Chronic medication
Yes	7 (18.4)	12 (31.6)	0.194
No	12 (31.6)	7 (18.4)
HTA medication
Yes	4 (10.5)	10 (26.3)	0.091
No	15 (39.5)	9 (23.7)

Data: media (standard deviation); Student’s t-test: p<0.05.
n (%), test: p<0.05.
Fasting glucose: normal ≤99 mg/dl; high ≥100 mg/dl.
Creatinine clearance: normal ≥90 ml/min; low ≤89 ml/min.
HTA: hypertension.